Speaker illustration

Doctor Gema Minana Escriva

Instituto de Investigacion Sanitaria INCLIVA, Valencia (Spain)

Serum neprilysin and recurrent hospitalizations after acute heart failure

Event: HEART FAILURE 2016

Topic: Prognosis (using biomarkers)

Session: Biomarkers

Thumbnail

ESC 365 is supported by

logo Novo Nordisk